CMS released a proposed rule this week that would boost hospitals’ inpatient payment rates by 2.6%. Hospitals groups have swiftly denounced this plan, arguing that this payment update is insufficient and will jeopardize hospitals’ financial stability.
A nationwide railroad strike could be coming mid-November. There are some key considerations that healthcare providers should take note of while they anticipate the possibility of a this strike, including having proactive conversations with their suppliers and identifying product alternatives.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Monkeypox was declared a public health emergency last week, but many healthcare professionals feel confused about how to best prepare for a potential outbreak in their area. While they wait for clearer guidance from the CDC and their local health departments, there are key actions they can take, such as decreasing stigma about the disease and advocating for increased access to vaccines, tests and treatments.
Group purchasing organization Premier is building a new healthcare network of health systems, employers and payers, and whose goals parallel those of large U.S. employers such as Walmart but are also meant to reach employees at smaller firms.
In a deal expected to close by the end of this year, Premier will scoop up Stanson Health, a Cedars-Sinai Medical Center spinout that was founded in 2013.
Almost all C-suite leaders surveyed reported that their inpatient pharmaceutical spending is on the rise, triggering a range of cost-saving initiatives through the organizations.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
A report from Reaction's Research Cloud highlights what providers are purchasing and which vendors they're selecting for everything from patient engagement tools to telehealth.
Hospitals are keenly aware that they risk attracting reimbursement penalties for every patient that contracts an infection while they’re hospitalized. A Premier analysis identified complications that could increase costs, lengths of stay and mortality. Although several of the conditions it identifies probably couldn’t be prevented by hospitals. But some hospitals have initiated programs to identify […]